TG Therapeutics Inc (NAS:TGTX)
$ 16.89 0.53 (3.24%) Market Cap: 2.61 Bil Enterprise Value: 2.51 Bil PE Ratio: 76.77 PB Ratio: 16.30 GF Score: 73/100

TG Therapeutics Inc ECTRIMS Investor & Analyst Event Transcript

Oct 14, 2021 / 04:30PM GMT
Release Date Price: $33.95 (+3.51%)
Operator

(Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to Jenna Bosco. Please go ahead.

Jenna Bosco
TG Therapeutics, Inc. - VP of IR & Senior VP of Corporate Communications

Good morning, and thank you all for joining us. I'm Jenna Bosco, the Head of Corporate Communications for TG Therapeutics. And we're excited to review with you all today the data presented at the ECTRIMS 2021 Congress.

Before we begin, I wanted to remind everyone that we anticipate making some forward-looking statements based on our current expectations. These statements involve risks and uncertainties that may cause our actual results to differ materially from those indicated. For a description of these risks, we encourage you to review the disclosures on this slide and also in our latest reports filed with the SEC, which are available on our corporate website at www.tgtherapeutics.com.

With that, let's kick things off with a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot